Experiment summary for ENCSR877ZUK

doi:10.17989/ENCSR877ZUK

Alternate accession: ENCSR920AQS

Summary

Status
released
Assay
ChIP-seq (Histone ChIP-seq)
Target
H3K36me3
Biosample summary
Homo sapiens CD4-positive, alpha-beta T cell treated with phorbol 13-acetate 12-myristate, ionomycin
Biosample Type
primary cell
Replication type
anisogenic
Treatments
phorbol 13-acetate 12-myristate (CHEBI:37537) , ionomycin (CHEBI:63954)
Nucleic acid type
DNA
Controls

Attribution

Roadmap Epigenomics Mapping Consortium
Lab
Bradley Bernstein, Broad
Award
U01ES017155 (Bradley Bernstein, Broad)
Project
Roadmap
External resources
Aliases
roadmap-epigenomics:ChIP-Seq analysis of H3K36me3 in human CD25- IL17- Th stim MACS cells_Jul-30-2011_15829, roadmap-epigenomics:ChIP-Seq analysis of H3K36me3 in human CD25- IL17- Th stim MACS cells_Jun-28-2012_51287
Date submitted
July 31, 2013
Date released
July 31, 2013
Reference Epigenome
ENCSR832UFG 
Submitter comment
The raw data from at least one replicate is not available to the ENCODE consortium.
Tags
Search for all Experiment with internal tag ENCYCLOPEDIAv2

Anisogenic replicates

Anisogenic replicate
Technical replicate
Summary
Biosample
Antibody
Library
13Homo sapiens CD4-positive, alpha-beta T primary cell treated with phorbol 13-acetate 12-myristate, ionomycinENCBS182XKPENCAB000ADUENCLB619YPB
22Homo sapiens CD4-positive, alpha-beta T primary cell treated with phorbol 13-acetate 12-myristate, ionomycinENCBS061FHJENCAB000ADUENCLB982PLH